Afya Stock-Based Compensation Growth & History (AFYA)

Afya's stock-based compensation was R$15.3M for fiscal 2025.

View full Afya company overview

Afya annual stock-based compensation history

Afya annual stock-based compensation

Fiscal yearPeriod endedStock-based compensationChangeGrowth
20252025-12-31R$15.3M−R$17.1M−52.76%
20242024-12-31R$32.4MR$889,000+2.82%
20232023-12-31R$31.5MR$261,000+0.83%
20222022-12-31R$31.3M−R$12.1M−27.90%
20212021-12-31R$43.4MR$10.8M+33.02%
20202020-12-31R$32.6MR$14.5M+80.03%
20192019-12-31R$18.1MR$16.0M+738.22%
20182018-12-31R$2.2M

Afya stock-based compensation trends

Over the last five fiscal years, Afya's stock-based compensation decreased from R$32.6M to R$15.3M, a change of −R$17.3M. The latest reported quarter, Q2 2026, shows R$8.1M.

About the metric

What stock-based compensation means

Stock-based compensation is the expense associated with equity awards such as restricted stock and employee options. It is a non-cash expense when recognized, but it can dilute existing shareholders unless offset by share repurchases.

Calculation and source

SEC-reported stock-based compensation

TickerStat standardizes share-based compensation reported in company SEC filings. The history shows recognized compensation expense or its cash-flow-statement adjustment, not the grant-date value of new awards or a forecast of future dilution. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Afya source filings ↗

Community posts

It’s quiet here.

No posts about AFYA yet. Start the conversation.

Write the first post